Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life
Authors
Keywords
-
Journal
JOURNAL OF AFFECTIVE DISORDERS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-02-04
DOI
10.1016/j.jad.2023.01.108
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression
- (2022) Guy M. Goodwin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment‐resistant major depressive disorder: Canadian expert consensus on definition and assessment
- (2021) Yuri E. Rybak et al. DEPRESSION AND ANXIETY
- Trial of Psilocybin versus Escitalopram for Depression
- (2021) Robin Carhart-Harris et al. NEW ENGLAND JOURNAL OF MEDICINE
- “Supporting Wellness”: A depression and bipolar support alliance mixed-methods investigation of lived experience perspectives and priorities for mood disorder treatment
- (2021) Emma Morton et al. JOURNAL OF AFFECTIVE DISORDERS
- Psychedelics and Psychedelic-Assisted Psychotherapy
- (2020) Collin M. Reiff et al. AMERICAN JOURNAL OF PSYCHIATRY
- Patients’ and clinicians’ perspectives on relevant treatment outcomes in depression: qualitative study
- (2020) Kaying Kan et al. BJPsych Open
- Treatment-Resistant Depression in a Real-World Setting: First Interim Analysis of Characteristics, Healthcare Resource Use, and Utility Values of the FondaMental Cohort
- (2020) Antoine Yrondi et al. Brain Sciences
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
- (2020) Alan K. Davis et al. JAMA Psychiatry
- Current and Common Definitions of Treatment-Resistant Depression: Findings from a Systematic Review and Qualitative Interviews
- (2019) Sage Brown et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Differences in Perceptions of Major Depressive Disorder Symptoms and Treatment Priorities Between Patients and Health Care Providers Across the Acute, Post-Acute, and Remission Phases of Depression
- (2019) Bernhard T. Baune et al. Frontiers in Psychiatry
- The burden of treatment-resistant depression: a systematic review of the economic and quality of life literature
- (2018) Karissa Johnston et al. JOURNAL OF AFFECTIVE DISORDERS
- Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
- (2018) Andrea Cipriani et al. LANCET
- Digit Symbol Substitution Test
- (2018) Judith Jaeger JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- (2016) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- (2016) Stephen Ross et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Characterization of Treatment Resistant Depression Episodes in a Cohort of Patients from a US Commercial Claims Database
- (2013) Nicole Kubitz et al. PLoS One
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
- (2011) M. Herdman et al. QUALITY OF LIFE RESEARCH
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
- (2010) Charles S. Grob et al. ARCHIVES OF GENERAL PSYCHIATRY
- What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies
- (2008) Abebaw Fekadu et al. JOURNAL OF AFFECTIVE DISORDERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started